Nvidia Faces Privacy Probe in China Over 300,000 AI Chips Amid Export Control Fallout

China's Cyberspace Administration recently summoned Nvidia (NASDAQ: NVDA) to answer tough questions about potential privacy vulnerabilities in its AI H20 chips. The key issue on the table: whether these chips include any hidden "backdoor" features that could compromise data security for Chinese users.

This call came shortly after U.S. legislators pushed for exporting AI chips that come with built-in tracking or location verification. In particular, a bill introduced by Senator Tom Cotton aims to force chipmakers to embed mechanisms that can track where their products end up, especially for high-tech gear heading to China.

Nvidia designed the H20 specifically for the Chinese market following tighter U.S. export controls implemented in late 2023, which restricted sales of advanced AI chips. Notably, the U.S. government recently backtracked on an earlier ban, allowing Nvidia to continue shipping these processors to China. Reportedly, Nvidia has already inked an order for a hefty 300,000 units with Taiwan Semiconductor Manufacturing Co., signaling solid demand despite geopolitical headwinds.

But the privacy concerns aren't Nvidia's only headache in China. The company is also tangled in a probe by China's State Administration for Market Regulation, which has flagged possible anti-monopoly law violations tied to Nvidia's acquisition of Mellanox Technologies in 2020. Chinese regulators claim Nvidia might not be meeting commitments made when the deal was approved, adding another layer of scrutiny.

While Nvidia hasn't publicly commented yet, the whole situation underscores the delicate balancing act for U.S. chipmakers operating in China's tightly controlled market-especially when national security and data privacy are involved. With regulators ramping up their oversight, the potential for chokepoints in supply chains remains real.

The stock is holding steady around $179, up roughly 2% following these developments, reflecting cautious optimism in the market despite regulatory buzz. Whether this turns into a broader regulatory crackdown or just a routine check remains to be seen.